Literature DB >> 17484877

Inhibition of T-cell proliferation by Helicobacter pylori gamma-glutamyl transpeptidase.

Christian Schmees1, Christian Prinz, Tilman Treptau, Roland Rad, Ludger Hengst, Petra Voland, Stefan Bauer, Lena Brenner, Roland M Schmid, Markus Gerhard.   

Abstract

BACKGROUND & AIMS: Helicobacter pylori colonizes the human gastric mucosa of >50% of the world's population. Most of the patients have no overt clinical symptoms. However, the infection is invariably associated with the development of active chronic gastritis, leading in some cases to the development of peptic ulcer disease, distal gastric adenocarcinoma, and mucosa-associated lymphoid tissue lymphoma. In contrast to most other pathogens, infection with H pylori persists lifelong, but reasons for the persistence remain obscure. CD4-positive T cells are crucial for bacterial elimination but are inhibited by H pylori. We aimed to identify the factor responsible for suppression of T-cell response and characterize this inhibitory effect on a cellular and molecular level.
METHODS: Using size-exclusion chromatography, sodium dodecyl sulfate/polyacrylamide gel electrophoresis, and a spectrophotometric enzyme assay, we identified the secreted gamma-glutamyl transpeptidase of H pylori (HPGGT) as the factor responsible for inhibition of T-cell proliferation.
RESULTS: Mutagenesis of HPGGT in different H pylori strains completely abrogated this inhibitory effect. Recombinantly expressed HPGGT protein showed full antiproliferative activity. Site-directed mutagenesis and application of the GGT inhibitor acivicin revealed that inhibition of T cells depends on catalytic activity of HPGGT. Cell cycle analysis of human T cells indicated that HPGGT was necessary and sufficient to induce G(1) arrest. Reduced levels of c-Myc and phosphorylated c-Raf protein suggest the disruption of Ras-dependent signaling by HPGGT.
CONCLUSIONS: GGT is a novel immunosuppressive factor of H pylori inhibiting T-cell proliferation by induction of a cell cycle arrest in the G(1) phase.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17484877     DOI: 10.1053/j.gastro.2007.02.031

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  63 in total

1.  Helicobacter pylori induces miR-155 in T cells in a cAMP-Foxp3-dependent manner.

Authors:  Lina Fassi Fehri; Manuel Koch; Elena Belogolova; Hany Khalil; Christian Bolz; Behnam Kalali; Hans J Mollenkopf; Macarena Beigier-Bompadre; Alexander Karlas; Thomas Schneider; Yuri Churin; Markus Gerhard; Thomas F Meyer
Journal:  PLoS One       Date:  2010-03-02       Impact factor: 3.240

Review 2.  Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori.

Authors:  Nina R Salama; Mara L Hartung; Anne Müller
Journal:  Nat Rev Microbiol       Date:  2013-05-08       Impact factor: 60.633

3.  Helicobacter pylori γ-glutamyl transpeptidase and vacuolating cytotoxin promote gastric persistence and immune tolerance.

Authors:  Mathias Oertli; Manuel Noben; Daniela B Engler; Raphaela P Semper; Sebastian Reuter; Joachim Maxeiner; Markus Gerhard; Christian Taube; Anne Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 4.  Structural and functional aspects of the Helicobacter pylori secretome.

Authors:  Giuseppe Zanotti; Laura Cendron
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

Review 5.  H. pylori infection, inflammation and gastric cancer.

Authors:  Qurteeba Qadri; Roohi Rasool; G M Gulzar; Sameer Naqash; Zafar A Shah
Journal:  J Gastrointest Cancer       Date:  2014-06

6.  Ammonium metabolism enzymes aid Helicobacter pylori acid resistance.

Authors:  Erica F Miller; Robert J Maier
Journal:  J Bacteriol       Date:  2014-06-16       Impact factor: 3.490

7.  Blood profile holds clues to role of infection in a premonitory state for idiopathic parkinsonism and of gastrointestinal infection in established disease.

Authors:  André Charlett; R John Dobbs; Sylvia M Dobbs; Clive Weller; Mohammad A A Ibrahim; Tracy Dew; Roy Sherwood; Norman L Oxlade; J Malcolm Plant; James Bowthorpe; Andrew J Lawson; Alan Curry; Dale W Peterson; Ingvar T Bjarnason
Journal:  Gut Pathog       Date:  2009-11-26       Impact factor: 4.181

8.  Cell-cycle inhibition by Helicobacter pylori L-asparaginase.

Authors:  Claudia Scotti; Patrizia Sommi; Maria Valentina Pasquetto; Donata Cappelletti; Simona Stivala; Paola Mignosi; Monica Savio; Laurent Roberto Chiarelli; Giovanna Valentini; Victor M Bolanos-Garcia; Douglas Scott Merrell; Silvia Franchini; Maria Luisa Verona; Cristina Bolis; Enrico Solcia; Rachele Manca; Diego Franciotta; Andrea Casasco; Paola Filipazzi; Elisabetta Zardini; Vanio Vannini
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

Review 9.  Helicobacter pylori gamma-glutamyl transpeptidase and its pathogenic role.

Authors:  Vittorio Ricci; Maria Giannouli; Marco Romano; Raffaele Zarrilli
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

Review 10.  Helicobacter pylori γ-glutamyl transpeptidase: a formidable virulence factor.

Authors:  Samantha Shi Min Ling; Khay Guan Yeoh; Bow Ho
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.